Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
PUT
KLA
KLAC
$259B
| $4.85M | ﹤0.01% |
272,000
+16,000
| +6% | +$268K |
|
|
SC
2027
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $4.85M | ﹤0.01% |
207,345
-121,798
| -37% | -$2.96M |
|
2028
CVB Financial
CVBF
$3.99B
| $4.84M | ﹤0.01% |
224,222
+67,422
| +43% | +$1.43M |
|
2029
Ultragenyx Pharmaceutical
RARE
$2.55B
| $4.83M | ﹤0.01% |
113,211
+86,164
| +319% | +$3.56M |
|
|
JJN
2030
DELISTED
iPath Series B Bloomberg Nickel Subindex Total ReturnSM ETN
JJN
| $4.83M | ﹤0.01% |
255,000
| – | – |
|
|
WRK
2031
CALL
DELISTED
WestRock Company
WRK
| $4.83M | ﹤0.01% |
112,600
+24,600
| +28% | +$959K |
|
2032
Medpace
MEDP
$16.5B
| $4.83M | ﹤0.01% |
57,419
+14,700
| +34% | +$1.14M |
|
2033
CALL
Elastic
ESTC
$7.81B
| $4.82M | ﹤0.01% |
75,000
+50,000
| +200% | +$3.66M |
|
2034
Itron
ITRI
$4.54B
| $4.81M | ﹤0.01% |
57,329
+17,576
| +44% | +$1.38M |
|
2035
SouthState Bank Corp
SSB
$10.5B
| $4.81M | ﹤0.01% |
55,450
+33,724
| +155% | +$2.74M |
|
|
DFVL
2036
DELISTED
iPath US Treasury 5-year Bull ETN
DFVL
| $4.81M | ﹤0.01% |
67,400
| – | – |
|
2037
PUT
TripAdvisor
TRIP
$1.26B
| $4.79M | ﹤0.01% |
157,700
+117,500
| +292% | +$3.96M |
|
2038
Ziff Davis
ZD
$1.98B
| $4.79M | ﹤0.01% |
58,774
+15,792
| +37% | +$1.31M |
|
2039
CALL
Old Dominion Freight Line
ODFL
$44.9B
| $4.78M | ﹤0.01% |
75,600
+38,700
| +105% | +$2.38M |
|
2040
Interactive Brokers
IBKR
$39.8B
| $4.78M | ﹤0.01% |
410,196
+402,464
| +5,205% | +$4.72M |
|
2041
Yelp
YELP
$1.41B
| $4.78M | ﹤0.01% |
137,300
+78,644
| +134% | +$2.67M |
|
2042
PUT
D.R. Horton
DHI
$42.3B
| $4.78M | ﹤0.01% |
90,600
+52,500
| +138% | +$2.8M |
|
2043
Four Corners Property Trust
FCPT
$2.75B
| $4.77M | ﹤0.01% |
169,292
+76,288
| +82% | +$2.13M |
|
2044
Voya Financial
VOYA
$9.19B
| $4.77M | ﹤0.01% |
78,245
-83,275
| -52% | -$4.7M |
|
|
IMMU
2045
PUT
DELISTED
Immunomedics Inc
IMMU
| $4.76M | ﹤0.01% |
225,100
+219,100
| +3,652% | +$3.87M |
|
2046
PUT
Genworth Financial
GNW
$3.71B
| $4.76M | ﹤0.01% |
1,081,300
+68,900
| +7% | +$290K |
|
2047
Qualys
QLYS
$6.35B
| $4.76M | ﹤0.01% |
57,051
+18,425
| +48% | +$1.53M |
|
2048
KBR
KBR
$4.8B
| $4.76M | ﹤0.01% |
155,942
+34,663
| +29% | +$975K |
|
2049
BHP
BHP
$230B
| $4.75M | ﹤0.01% |
97,298
-63,914
| -40% | -$2.9M |
|
|
CUB
2050
DELISTED
Cubic Corporation
CUB
| $4.75M | ﹤0.01% |
74,669
+43,436
| +139% | +$2.94M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.